Post-Hospital Discharge Care: A Retrospective Cohort Study Exploring the Value of Pharmacist-Enhanced Care and Describing Medication-Related Problems
- PMID: 29439095
- DOI: 10.18043/ncm.79.1.4
Post-Hospital Discharge Care: A Retrospective Cohort Study Exploring the Value of Pharmacist-Enhanced Care and Describing Medication-Related Problems
Abstract
BACKGROUND Medication-related problems occur at high rates during care transitions. Evidence suggests that pharmacists are well-suited to identify and resolve medication-related problems during hospital admission and at discharge. Additional evidence is needed to understand the impact of face-to-face pharmacist visits in primary care after discharge. The purpose of the study was to describe medication-related problems found during face-to-face pharmacist visits in a medical home after hospital discharge.METHODS A retrospective cohort study was conducted within an academic primary care center staffed by family medicine trained physicians that evaluated patients who attended a hospital follow-up visit with pharmacist-enhanced care (N = 86) versus usual care (N = 86). The primary objective was to describe medication-related problems identified by pharmacists using a modified individualized Medication Assessment and Planning tool for patients receiving pharmacist-enhanced care. Secondary analyses were also conducted to compare 30-day and 60-day hospital readmission and emergency department visit rates in those exposed to pharmacist-enhanced care versus those who were not.RESULTS At baseline, the mean hospitalizations in the prior year were 1.1 ± 1.7 (pharmacist-enhanced care) and 0.76 ± 1.2 (usual care), indicating a low initial readmission risk. Of patients receiving pharmacist-enhanced care, 97.7% were found to have at least 1 medication-related problem, with an average of 4.36 medication-related problems per patient. The 30-day readmission rate was lower, but not significantly different between groups (8.1% for pharmacist-enhanced care versus 12.8% for usual care; adjusted odds ratio (OR), 0.47; 95% confidence interval (CI), 0.16-1.36).LIMITATIONS Limitations include the retrospective cohort study design and small sample size. Medication-related problems were identified and collected prospectively during pharmacist visits.CONCLUSION Medication-related problems are ubiquitous after hospital discharge. Larger prospective studies will be needed to understand the potential value of pharmacist-enhanced care during hospital follow-up visits on readmission rates in low-risk patient populations receiving care within a primary care medical home.
©2018 by the North Carolina Institute of Medicine and The Duke Endowment. All rights reserved.
Similar articles
-
Impact of a comprehensive pharmacist medication-therapy management service.J Med Econ. 2015;18(10):828-37. doi: 10.3111/13696998.2015.1052463. Epub 2015 Jun 9. J Med Econ. 2015. PMID: 25985395 Clinical Trial.
-
Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate.Am J Health Syst Pharm. 2015 Jun 1;72(11 Suppl 1):S36-42. doi: 10.2146/sp150011. Am J Health Syst Pharm. 2015. PMID: 25991594
-
Inpatient pharmacists' patient referrals to a transitions-of-care pharmacist: Evaluation of an automated referral process.J Am Pharm Assoc (2003). 2018 Sep-Oct;58(5):540-546. doi: 10.1016/j.japh.2018.05.007. Epub 2018 Jul 17. J Am Pharm Assoc (2003). 2018. PMID: 30017369
-
Inpatient pharmacists using a readmission risk model in supporting discharge medication reconciliation to reduce unplanned hospital readmissions: a quality improvement intervention.BMJ Open Qual. 2022 Mar;11(1):e001560. doi: 10.1136/bmjoq-2021-001560. BMJ Open Qual. 2022. PMID: 35241436 Free PMC article. Review.
-
Pharmacist-led interventions at hospital discharge: a scoping review of studies demonstrating reduced readmission rates.Int J Clin Pharm. 2025 Feb;47(1):15-30. doi: 10.1007/s11096-024-01821-y. Epub 2024 Dec 9. Int J Clin Pharm. 2025. PMID: 39652248 Free PMC article.
Cited by
-
A Multi-method Exploratory Evaluation of a Service Designed to Improve Medication Safety for Patients with Monitored Dosage Systems Following Hospital Discharge.Drug Saf. 2023 Oct;46(10):1021-1037. doi: 10.1007/s40264-023-01342-z. Epub 2023 Oct 11. Drug Saf. 2023. PMID: 37819463 Free PMC article.
-
Advancing Pharmacy Practice through an Innovative Ambulatory Care Transitions Program at an Academic Medical Center.Pharmacy (Basel). 2020 Mar 12;8(1):40. doi: 10.3390/pharmacy8010040. Pharmacy (Basel). 2020. PMID: 32178259 Free PMC article.
-
Self-Efficacy Intervention Programs in Patients with Chronic Obstructive Pulmonary Disease: Narrative Review.Int J Chron Obstruct Pulmon Dis. 2021 Dec 18;16:3397-3403. doi: 10.2147/COPD.S338720. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34955635 Free PMC article. Review.
-
Clinical and economic effectiveness of a pharmacy and primary care collaborative transition of care program.J Am Pharm Assoc (2003). 2023 Nov-Dec;63(6):1722-1730.e3. doi: 10.1016/j.japh.2023.08.014. Epub 2023 Aug 21. J Am Pharm Assoc (2003). 2023. PMID: 37611896 Free PMC article. Clinical Trial.
-
Incorporating Oral Health Considerations for Medication Management in Care Transitions.Pharmacy (Basel). 2020 Apr 16;8(2):67. doi: 10.3390/pharmacy8020067. Pharmacy (Basel). 2020. PMID: 32316374 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources